Is This the Shopify (TSX:SHOP) of Legal Marijuana?

Namaste Technologies Inc. (TSXV:N) is trying to infuse technology into the legal marijuana sector.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Since legalization last year, marijuana stocks have been on an unprecedented growth spurt. The combined valuation of all the stocks in the industry has ballooned multiple times since the bill was first introduced in parliament.

However, as investors have poured billions into the top producers and sellers, savvy entrepreneurs have been working on building the infrastructure the ecosystem desperately needs. The best example of this is Toronto-based tech startup Namaste Technologies (TSXV:N).

Founded in 2005, the company has focused on infusing the legal marijuana market with technology. Over the past 14 years, the Namaste team has managed to create an online platform for cannabis-related services, vaporizers, and smoking paraphernalia served to over 1.5 million customers across the globe. According to its website, the company plans to become the biggest online store for all things green. In other words, it’s the Amazon or Shopify equivalent of the cannabis sector.

Namaste’s network of e-commerce sites and software platforms spans three continents and 20 countries and is serviced by five warehouses.

Cannmart, the company’s core subsidiary, is one of the first Canadian online marketplaces for cannabis products. The team has struck supply agreements with a number of small cultivators in British Columbia to deliver high-quality, high-potency products to niche connoisseurs across the country.

Meanwhile, the company has also been investing heavily in innovative technologies to drive the industry forward. Its artificial intelligence platform, Findify, leverages the data collected on the company’s journal app, Uppy, to study the medical impacts of different strains and suggest the right one to users.

The team has also received approval from Health Canada for its NamasteMD app — a medical cannabis consultations platform for eligible Canadians.

As far as I can tell, this tech-driven, vertically integrated approach is rare in this sector. The market opportunity for online sales alone is huge, but the company is going the extra mile with critical data collection and AI algorithms to enhance the experience of consuming these products.

However, nearly every aspect of the business model is in its earliest phase of development at the moment. The company generated only $18.6 million in revenue over the past 12 months and has negative cash flow. Like other startups in this space, the company’s investment merit hinges on the growth potential and current valuation.

In terms of growth, Namaste has been on par with the rest of the industry. Annual sales are up 69%, driven by impressive growth of 364% in Canada, 261% in Germany, 188% in Brazil, 98% in Australia, 45% in United Kingdom, over the past 12 months.

Meanwhile, the stock trades at a mere 11.6 times annual sales. In the legal marijuana sector, this ratio is unusually low. The company also has $34.4 million in cash on its book, which equates to $0.11 per share. Shares are currently trading at $0.70.

Bottom line

Namaste technology is focused on combining artificial intelligence and e-commerce to dominate the market for cannabis sales online. All the verticals it has recently added look promising, and the stock’s valuation seems justified considering the potential for growth.

Investors seeking an opportunity in the overheated cannabis market may want to take a closer look at Namaste.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in the companies mentioned. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. David Gardner owns shares of Amazon. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of Amazon, Shopify, and Shopify. Shopify is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »